FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
📰 Original Source
Read full article at Wired →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.